Cite
APA Citation
Macy, M., Cash, T., Pinto, N., Pressey, J., Szalontay, L., Furman, W., Bukowinski, A., Foster, J., Friedman, G., HaDuong, J., Fox, E., Weigel, B., Grevel, J., Huang, F., Phelps, C., Childs, B., Chung, J., Chaturvedi, S., Schulz, A., & DuBois, S. (n.d.). phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. European journal of cancer, 174, S28–S29. http://access.bl.uk/ark:/81055/vdc_100168600225.0x000040